Purines and neutrophil leukocytes

被引:69
作者
Fredholm, BB
机构
[1] Dept. of Physiology and Pharmacology, Sect. of Molecular Neuropharmacology, Karolinska Institute
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1997年 / 28卷 / 03期
关键词
adenosine receptors; nucleotides; adenosine uptake; xanthines;
D O I
10.1016/S0306-3623(96)00169-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Adenosine is a normal constituent of all body fluids and its levels are raised, for example, by hypoxia and ischemia. In addition, both adenosine and ATP can be released by endothelial cells and neutrophils in response to physiologic stimulation. 2. Human neutrophil leukocytes possess multiple adenosine receptors and P-2 purinoceptors. 3. ATP can increase intracellular Ca2+ levels in neutrophils, cause degranulation and enzyme release, potentiate the oxidative burst and enhance their adhesion to the endothelium. ATP is broken down to adenosine by ecto enzymes. Via A(1) receptors, adenosine can increase neutrophil chemotaxis and, via A(2A) receptors, it can decrease the oxidative burst, degranulation and adhesion to endothelium. 4. Adenosine and adenine nucleotides are important endogenous modulators of neutrophil functions, and drugs may exert important actions via purinoceptors on neutrophil leukocytes. Copyright (C) 1997 Elsevier Science Inc.
引用
收藏
页码:345 / 350
页数:6
相关论文
共 86 条
  • [1] DIRECT ACTIVATION OF PHOSPHOLIPASE-A2 BY GTP-BINDING PROTEIN IN HUMAN PERIPHERAL POLYMORPHONUCLEAR LEUKOCYTES
    ANDO, M
    FURUI, H
    SUZUKI, K
    TAKI, F
    TAKAGI, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (02) : 708 - 713
  • [2] ARCH JRS, 1978, ESSAYS BIOCHEM, V14, P88
  • [3] AXTELL RA, 1990, BLOOD, V75, P1324
  • [4] BALAZOVICH KJ, 1990, J IMMUNOL, V144, P631
  • [5] THE ROLE OF SMALL GTP-BINDING PROTEINS IN LEUKOCYTE FUNCTION
    BOKOCH, GM
    KNAUS, UG
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (01) : 98 - 105
  • [6] INHIBITION OF RAP1A BINDING TO CYTOCHROME-B558 OF NADPH OXIDASE BY PHOSPHORYLATION OF RAP1A
    BOKOCH, GM
    QUILLIAM, LA
    BOHL, BP
    JESAITIS, AJ
    QUINN, MT
    [J]. SCIENCE, 1991, 254 (5039) : 1794 - 1796
  • [7] Burnstock G, 1980, Prog Biochem Pharmacol, V16, P141
  • [8] IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR
    BURNSTOCK, G
    KENNEDY, C
    [J]. GENERAL PHARMACOLOGY, 1985, 16 (05): : 433 - 440
  • [9] CAPECCHI PL, 1993, ARZNEIMITTEL-FORSCH, V43-2, P992